Automated Cell Culture Equipment Market Research Report Information by Lab Automation Type (Modular Automation and Whole Lab Automation), by Product Type (Consumables, Equipment and Software), Application (Biopharmaceutical Production, Tissue Engineering, Vaccine Production, Gene Therapy & Regenerative Medicine, Stem Cell Therapy, Toxicity Testing and Diagnostics), End User (Pharmaceutical & Biotechnology Companies, Research and Academic Institutes and Hospitals and Diagnostic Laboratories) - Forecast till 2030

Automated Cell Culture Equipment Market Overview

The Automated Cell Culture Equipment Market is projected to reach USD 11845.82 Million by 2030 at 7.90% CAGR during the forecast period 2022-2030.

Biological experimentation and drug origination are the two basic extents of cell culture. Handling the sterile solution is a cumbersome task and is very much prone to spoilage. This process of handling and transporting the solution to different containers can be made easy through automated cell culture systems. With the help of improved technology and automated cell culture equipment, the cultivation and preservation of cells and tissues in desired circumstances have become easier. An automated cell culture system guarantees uniformity in the process. The process becomes more cost-effective and less time-consuming. Through this system, a lab technician can also monitor and record developments easily.

Covid19 Analysis

Researchers from across the globe are working on developing a vaccine or an antidote for the coronavirus. The strains of SARS-Cov-2 are obtained from a patient’s body and then the researchers work on the automated cell culture system to extract the primary and stem cell lines from the samples obtained. This sudden surge in the field of pharmaceuticals and its related Research & Development has increased the automated cell culture equipment market share. This equipment is needed for rapid testing and trial of coronavirus.

Automated Cell Culture Equipment Market Revenue, by lab automation type, 2018 (% share)

Sources: MRFR Analysis

Market Dynamics

Drivers

The widespread presence of chronic diseases such as cancer, HIV, Tuberculosis, calls for the requirement of new and useful drugs. In a report, the National Cancer Institute indicated that the estimated number of cases of cancer diagnosed and reported in the US in 2018 was 1,735,350. The numbers are sloping upwards in every part of the world. This will increase the automated cell culture market share.

Opportunities

The hike in the number of tests being done regularly due to the prevalent infectious diseases leads to the increased demand for testing and research equipment. As the automated cell, culture systems are time and cost-effective, the results can be drawn instantly. This has increased automated cell culture equipment market size.

Restraints

The environment is dynamic as changes are occurring in the blink of an eye. There is a dearth of skilled workers who can operate the instruments and machines. Automated cell culture systems can prove to be cost-effective in the long run but their maintenance is a costly affair.

Value Chain Analysis

Automated cell culture equipment reduces all the redundant activities on part of the workers. It has decreased manual labor. It also ensures uniformity and consistency in managing the material. It, thus, ensures the quality of the research and the material. The efficiency is also increased as several people can work on the same samples but the outcomes will not fluctuate.

Automated Cell Culture Equipment Market Share, by Region, 2018 (%)     

Sources: MRFR Analysis

Market Segmentation

Automated cell culture market share can be classified into various segments. These are: based on lab automation type, based on product type, based on application, and based on end-user.

Based on lab automation type:

It can be further subdivided into two types, namely, modular automation and whole lab automation. The modular automation is anticipated to capture the largest automated cell culture equipment market share of 67.20% by the end of the year 2025. It is helpful in pre-clinical trials as well as in-depth research. Whole lab automation helps in sample arrangements as well as screening. 

Based on product type:

An automated cell culture system provides three types of products, namely, consumables, equipment, and software. The software runs through the computer system and enables the lab technicians to give commands and gets desired results. Consumables are the products that need constant supplies as they are to be replaced with every use. Equipment is necessary to carry on the research process. 

Based on application:

Automated cell culture equipment can be easily applied to different fields such as biopharmaceutical productions, vaccine production, tissue engineering, stem cell therapy, and toxicity testing, general diagnosis, drug screening and development, and others. 

Based on end-user:

Pharmaceutical and biotechnological industries, hospitals and diagnostic labs, pathological labs, research, and academic institutes comprise automated cell culture equipment market size. This equipment is required in the labs for regular testing, maintaining records as well as monitoring the results.

Regional Analysis

The automated cell culture market is leaving its impression in every corner of the world. The regions include America, Europe, Asia-pacific, Middle-East, and Africa.

The automated cell culture equipment market share in America can be divided into North America, which can further be divided in the US and Canada, and Latin America. America, having a large population, robust healthcare infrastructure, and due to the increase in Research & Development, is the greatest consumer of automated cell culture equipment. America alone had a market share of 42.54% in the year 2018. It is expected that this share will increase double folds in the coming years

The European market can be further segmented into Western Europe, which has further branches in Germany, France, Italy, UK, Spain, and Eastern Europe. Europe is the second-largest customer of automated cell culture equipment.

In Asia-pacific regions, the branches can be seen in the areas such as China, India, Japan, South Korea, and Australia. It holds the third-largest position in the automated cell culture equipment market share. It is also estimated to grow tremendously throughout the forecast.

The Middle East and Africa are growing at a slower pace but will provide a promising automated cell culture equipment market in the coming future. This is because there are many developing nations in this region.

Competitive Landscape

The list of major key players involved in the automated cell culture equipment market research is as follows:

• Tecan Trading AG


• Siemens


• Pfizer Inc.


• Hitachi, Ltd


• Thermo Fisher Scientific Inc.


• Sartorius AG


• Hamilton Company


• Beckman Coulter, Inc.


• F. Hoffmann-La Roche Ltd.


• Perkinelmer, Inc.


• Anton Paar GmBH.Becton, Dickinson, and Company (U.S.)


• HiMedia Laboratories (India)


• GE Healthcare (U.S.)


• Lonza (Switzerland)


• CellGenix GmbH (Germany).

The above-listed companies work on the screening and development of new as well as useful drugs. They invest in the latest technologies to perform the tasks more effectively and efficiently. Automated cell culture systems provide them with equipment that increases the feasibility of their processes and thus, gives durable outcomes.

Recent Development

Various developments are seen in the automated cell culture equipment market which is as follows:

• In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.


• In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.


• In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.


• In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.


• In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 

Report Overview

This market research report of automated cell culture equipment market includes the following elements:

• Automated Cell Culture Equipment Market Overview


• COVID19 Analysis


• Market Dynamics


• Value Chain Analysis


• Automated Cell Culture Equipment Market Segmentation


• Regional Analysis


• Competitive Landscape


• Recent Developments

This automated cell culture equipment market research report enumerates how the cell culture system works. The automation of the cell culture system will give certain benefits to the companies. It will lead to more accuracy in the functioning; it will reduce the cost and time, and it will lower the chances of inaccuracy and miscalculations. The widespread presence of chronic diseases such as cancer, HIV, Tuberculosis, calls for the requirement of new and useful drugs. It becomes the major driving force of the automated cell culture equipment market. It has decreased the manual labor and redundant activities by the workers.

Report Scope:

Report Attribute/Metric	Details
Market Size	2030: USD 11845.82 Million
CAGR	7.90% (2022-2030)
Base Year	2021
Forecast Period	2022-2030
Historical Data	2020
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Lab Automation Type, Product Type, Application and End User
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Tecan Trading AG, Hamilton Company, Beckman Coulter, Inc., Pfizer Inc., Hitachi, Ltd, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Anton Paar GmBH, Sartorius AG, Perkinelmer, Inc., and Siemens
Key Market Opportunities	Growing research & development (R&D) initiatives in the pharmaceutical industry
Key Market Drivers	The rising prevalence of cancer and other chronic disorders demands the discovery of newer and more effective drugs for their treatment. The growing incidence of cancer and other chronic diseases is anticipated to fuel the market growth

Frequently Asked Questions (FAQ) :